Trademark Overview
On Thursday, January 24, 2008, a trademark application was filed for DCA with the United States Patent and Trademark Office. The USPTO has given the DCA trademark a serial number of 77380159. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, December 10, 2008. This trademark is owned by AGENNIX INCORPORATED. The DCA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of elevated circulating cholesterol, vascular inflammation, atherosclerosis, cardiovascular disease, diabetes mellitus, infection and/or inflammation in immunosuppressed subjects, cancer, organ transplant rejection and graft-versus-host-disease, bacteremia, sepsis, septic shock, Acute Respiratory Distress Syndrome, pain, wounds, respiratory disorders, neurofibromatosis, rheumatoid arthritis, Waginer's granulomatosis, Kawasaki's disease, lupus erathematosis, midline granuloma, inflammatory bowel disease, osteoarthritis, leiomyomas, adenomas, lipomas, hemangiomas, fibromas, vascular occlusion, restenosis, pre-neoplastic lesions, carcinoma in situ, oral hairy leukoplakia, psoriasis, pre-leukemias, anemia with excess blasts, and myelodysplastic syndrome
